From: Development and validation of COMPASS: clinical evidence of orphan medicinal products – an assessment tool
Inter-rater agreement (%)
Overall
Part 1
Part 2
Part 3
1st pilot round (n = 5)
87.1
92.2
76.9
2nd pilot round (n = 4)
NA
77.5
3rd round (n = 29)
86.4